• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Prempro 0.3 mg/1.5 mg and 0.45 mg/1.5 mg (conjugated estrogens/medroxyprogesterone acetate tablets)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- May 2009

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.

 

Summary View

 

PATIENT PACKAGE INSERT

    What are the ingredients in Prempro and Premphase?

  • incorporates information on the reformulated Prempro 0.3 mg/1.5 mg and 0.45 mg/1.5 mg tablets